Emerging Biosimilars in Therapeutics

 In the field of biologics, the new avenue has created towards clinicians because explorations have created for better disease management. In the treatment of elements like psoriasis, rheumatic arthritis, certain cancer inflammation, bowel diseases etc. Showed some good outcomes because of using biologics. Biosimilar insulin which are newly formed are likely to enter the insulin landscape as patents for major branded insulin products ready to expire in the next few years. The emerging biosimilar like filgrastim, pegfilgrastim, recombinant blood products, therapeutic products vaccine biosimilar, anti-bodies growth hormones, biosimilar peptide, all these are used to sound knowledge on biosimilars development on drugs.

  • Rapid screening methods
  • Environmental Monitoring
  • Particulate matter



    Related Conference of Emerging Biosimilars in Therapeutics

    November 27-27, 2021

    Drug Formulation Bioavailability 2021

    London, UK
    February 07-08, 2022

    World Congress on Pharmaceutical Chemistry

    Paris, France

    Emerging Biosimilars in Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in